8-K - VistaGen Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

VistaGen Therapeutics, Inc. filed an 8-K on February 20, 2026, with Items listed as N/A. An external hint references Item 5.02 regarding a potential departure, election, or appointment of directors or officers effective February 1, but no specific details are disclosed in the document content.

Key Takeaways

1Filing date: 2026-02-20

2Form type: 8-K

3Items: N/A

4External hint: Item 5.02 on February 1

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers. On February 1

Management Change

Exhibits (1)

8-K